Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 193,652	$ 372,002
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	500	500
Amortization of debt discount to interest expense	72,122	141,121
Gain on change in derivative liabilities	(1,202,921)	(1,453,533)
Common stock issued for services	0	20,000
Stock option compensation	745,448	736,915
Changes in assets and liabilities: Increase (decrease) in:
Accounts payable	8,868	13,165
Accounts payable - related party	0	(10,000)
Accrued expenses	(506)	(360)
Accrued interest, notes payable	2,625	9,234
Net cash used in operating activities	(180,212)	(170,956)
Cash flows from investing activities:
Increase in deposits	0	(500)
Net cash used in investing activities	0	(500)
Cash flows from financing activities:
Proceeds from convertible notes payable	0	75,000
Proceeds from the issuance of Series E preferred stock	172,000	120,000
Repayment of convertible notes payable	0	(20,000)
Net cash provided by financing activities	172,000	175,000
Net increase (decrease) in cash	(8,212)	3,544
Cash, beginning of period	31,113	68,366
Cash, end of period	22,901	71,910
Supplemental Disclosure:
Cash paid for income taxes	0	0
Cash paid for interest	0	439
Non-cash financing and investing activities:
Common shares issued in conversion of debt	40,971	92,750
Settlement of derivative liabilities	30,758	66,341
Debt discount for derivative liabilities	0	613,247
Common shares issued in conversion of Series B preferred stock	0	22,100
Derivative liability for consultant stock options	$ 0	$ 545,462